Hussman Strategic Advisors, Inc. Ironwood Pharmaceuticals Inc Transaction History

Hussman Strategic Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	SELL	$8.79 - $11.51 $536,190 - $702,110	-61,000 Reduced 49.19%	63,000 $720,000
Q2 2023 Aug 03, 2023	SELL	$10.1 - $11.6 $323,200 - $371,200	-32,000 Reduced 20.51%	124,000 $1.32 Million
Q2 2022 Sep 12, 2022	BUY	$11.05 - $12.72 $1.15 Million - $1.32 Million	104,000 Added 200.0%	156,000 $1.8 Million
Q1 2022 May 04, 2022	SELL	$10.61 - $12.88 $275,860 - $334,880	-26,000 Reduced 33.33%	52,000 $654,000
Q4 2021 Jan 31, 2022	BUY	$10.86 - $13.95 $847,080 - $1.09 Million	78,000 New	78,000 $909,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $562M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.